Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T80975 | Target Info | |||
Target Name | Vascular endothelial growth factor receptor 2 (KDR) | ||||
Synonyms | VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyrosine kinase receptor flk-1; Kinase insert domain receptor; Fetal liver kinase 1; FLK1; FLK-1; CD309 | ||||
Target Type | Successful Target | ||||
Gene Name | KDR | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 1 Acyltransferases | + | |||
Interacting Target Name | Signal transduction protein CBL (CBL) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF55; RING-type E3 ubiquitin transferase CBL; RING finger protein 55; Proto-oncogene c-CBL; E3 ubiquitin-protein ligase CBL; C-Cbl; CBL2; Casitas B-lineage lymphoma proto-oncogene | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Reconstituted Complex | [2] | |||
Ester hydrolases | [+] 2 Ester hydrolases | + | |||
Interacting Target Name | Protein-tyrosine phosphatase SHP-2 (PTPN11) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein phosphatase non-receptor type 11; SH-PTP3; SH-PTP2; SHPTP2; SHP-2; SHP2; PTP-2C; PTP2C; PTP-1D; Protein-tyrosine phosphatase SHP2; Protein-tyrosine phosphatase 2C; Protein-tyrosine phosphatase 1D | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [3] | |||
2 | Far Western | [3] | |||
3 | Yeast two hybrid | [4] | |||
Interacting Target Name | Protein-tyrosine phosphatase SHP-1 (PTPN6) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein phosphatase non-receptor type 6; SH-PTP1; PTP-1C; PTP1C; Protein-tyrosine phosphatase 1C; Hematopoietic cell protein-tyrosine phosphatase; HCP | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Co-localization | [5] | |||
3 | Yeast two hybrid | [4] | |||
Growth factors | [+] 1 Growth factors | + | |||
Interacting Target Name | Vascular endothelial growth factor A (VEGFA) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | VPF; VEGF-A; VEGF; Vascular permeability factor; Vascular endothelial growth factor A | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Biochemical Activity | [6] | |||
2 | Co-localization | [7] | |||
3 | Reconstituted Complex | [8] | |||
Kinases | [+] 1 Kinases | + | |||
Interacting Target Name | Vascular endothelial growth factor receptor 1 (FLT-1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | VEGFR-1; VEGFR1; VEGF-1 receptor; Vascular permeability factor receptor; Tyrosine-protein kinase receptor FLT; Tyrosine-protein kinase FRT; FRT; Fms-like tyrosine kinase 1; FLT | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Biochemical Activity | [10] | |||
Other proteins | [+] 1 Other proteins | + | |||
Interacting Protein Name | SHC-transforming protein 2 (SHC2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SCK; SHCB; SLI | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Reconstituted Complex | [11] | |||
3 | Yeast two hybrid | [12] | |||
4 | Yeast two hybrid | [13] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Shear Stress Regulates the Flk-1/Cbl/PI3K/NF-B Pathway Via Actin and Tyrosine Kinases. Cell Mol Bioeng. 2009 Sep 1;2(3):341-350. | ||||
REF 2 | A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis. Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5413-8. | ||||
REF 3 | Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. Circ Res. 2006 Jan 6;98(1):45-54. | ||||
REF 4 | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. Mol Cell. 2017 Jan 19;65(2):347-360. | ||||
REF 5 | TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation. FASEB J. 2017 May;31(5):2001-2012. | ||||
REF 6 | ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J Biol Chem. 2003 Jun 27;278(26):23656-65. | ||||
REF 7 | Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor. Mol Cancer. 2015 Feb 3;14:19. | ||||
REF 8 | Distinct heparin binding sites on VEGF165 and its receptors revealed by their interaction with a non sulfated glycoaminoglycan (NaPaC). Biochim Biophys Acta. 2008 Apr;1780(4):723-32. | ||||
REF 9 | N-terminal cleavage and release of the ectodomain of Flt1 is mediated via ADAM10 and ADAM 17 and regulated by VEGFR2 and the Flt1 intracellular domain. PLoS One. 2014 Nov 11;9(11):e112794. | ||||
REF 10 | Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 2003 Jul;9(7):936-43. | ||||
REF 11 | Sck is expressed in endothelial cells and participates in vascular endothelial growth factor-induced signaling. Oncogene. 2002 Sep 12;21(41):6307-16. | ||||
REF 12 | The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells. Biochem J. 2000 Apr 15;347(Pt 2):501-9. | ||||
REF 13 | Sck interacts with KDR and Flt-1 via its SH2 domain. Biochem Biophys Res Commun. 1998 Oct 9;251(1):77-82. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.